| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5273927
Max Phase: Preclinical
Molecular Formula: C13H26N4O2
Molecular Weight: 270.38
Associated Items:
Representations
Canonical SMILES: CCCCCCCCn1cc(C(N)(CO)CO)nn1
Standard InChI: InChI=1S/C13H26N4O2/c1-2-3-4-5-6-7-8-17-9-12(15-16-17)13(14,10-18)11-19/h9,18-19H,2-8,10-11,14H2,1H3
Standard InChI Key: UIIHYZWCYUJUSP-UHFFFAOYSA-N
Associated Targets(Human)
Sphingomyelin phosphodiesterase 13561 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 270.38 | Molecular Weight (Monoisotopic): 270.2056 | AlogP: 0.78 | #Rotatable Bonds: 10 |
| Polar Surface Area: 97.19 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.46 | CX LogP: 1.24 | CX LogD: 0.90 |
| Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.55 | Np Likeness Score: -0.79 |
References
| 1. Skácel J, Slusher BS, Tsukamoto T.. (2021) Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network., 64 (1.0): [PMID:33395289] [10.1021/acs.jmedchem.0c01664] |
Source
Source(1):